Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Int J Pharm ; 660: 124315, 2024 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-38852747

RESUMEN

The compendial USP〈701〉 disintegration test method offers a crucial pass/fail assessment for immediate release tablet disintegration. However, its single end-point approach provides limited insight into underlying mechanisms. This study introduces a novel calorimetric approach, aimed at providing comprehensive process profiles beyond binary outcomes. We developed a novel disintegration reaction calorimeter to monitor the heat release throughout the disintegration process and successfully obtained enthalpy change profiles of placebo tablets with various porosities. The formulation comprised microcrystalline cellulose (MCC), anhydrous lactose, croscarmellose sodium (CCS), and magnesium stearate (MgSt). An abrupt temperature rise was observed after introducing the disintegration medium to tablets, and the relationship between the heat rise time and the tablet's porosity was investigated. The calorimeter's sensitivity was sufficient to discern distinct heat changes among individual tablets, and the analysis revealed a direct correlation between the two. Higher porosity corresponded to shorter heat rise time, indicating faster disintegration rates. Additionally, the analysis identified a concurrent endothermic process alongside the anticipated exothermic phenomenon, potentially associated with the dissolution of anhydrous lactose. Since lactose is the only soluble excipient within the blend composition, the endothermic process can be attributed to the absorption of heat as lactose molecules dissolve in water. The findings from this study underscore the potential of utilising calorimetric methods to quantify the wettability of complex compounds and, ultimately, optimise tablet formulations.


Asunto(s)
Calorimetría , Celulosa , Excipientes , Calor , Lactosa , Ácidos Esteáricos , Comprimidos , Lactosa/química , Celulosa/química , Excipientes/química , Porosidad , Ácidos Esteáricos/química , Calorimetría/métodos , Solubilidad , Carboximetilcelulosa de Sodio/química , Química Farmacéutica/métodos , Liberación de Fármacos , Composición de Medicamentos/métodos
2.
Nucleic Acids Res ; 52(1): 243-258, 2024 Jan 11.
Artículo en Inglés | MEDLINE | ID: mdl-37971291

RESUMEN

The primase/polymerase PRIMPOL restarts DNA synthesis when replication is arrested by template impediments. However, we do not have a comprehensive view of how PRIMPOL-dependent repriming integrates with the main pathways of damage tolerance, REV1-dependent 'on-the-fly' lesion bypass at the fork and PCNA ubiquitination-dependent post-replicative gap filling. Guided by genome-wide CRISPR/Cas9 screens to survey the genetic interactions of PRIMPOL in a non-transformed and p53-proficient human cell line, we find that PRIMPOL is needed for cell survival following loss of the Y-family polymerases REV1 and POLη in a lesion-dependent manner, while it plays a broader role in promoting survival of cells lacking PCNA K164-dependent post-replicative gap filling. Thus, while REV1- and PCNA K164R-bypass provide two layers of protection to ensure effective damage tolerance, PRIMPOL is required to maximise the effectiveness of the interaction between them. We propose this is through the restriction of post-replicative gap length provided by PRIMPOL-dependent repriming.


Asunto(s)
Daño del ADN , ADN Primasa , ADN Polimerasa Dirigida por ADN , Humanos , ADN Primasa/genética , ADN Primasa/metabolismo , Replicación del ADN , Enzimas Multifuncionales/genética , Enzimas Multifuncionales/metabolismo , Antígeno Nuclear de Célula en Proliferación/genética , Antígeno Nuclear de Célula en Proliferación/metabolismo , ADN Polimerasa Dirigida por ADN/metabolismo
3.
Int J Pharm ; 635: 122726, 2023 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-36812951

RESUMEN

The disintegration process of pharmaceutical solid dosage forms commences on contact with the dissolution medium and continues with subsequent spontaneous imbibition of the medium in the tablet matrix. Identifying the location of the liquid front in situ during imbibition, therefore, plays a significant role in understanding and modelling the disintegration process. Terahertz pulsed imaging (TPI) technology can be used to investigate this process by its ability to penetrate and identify the liquid front in pharmaceutical tablets. However, previous studies were limited to samples suitable for a flow cell environment, i.e. flat cylindrical disk shapes; thus, most commercial tablets could only be measured with prior destructive sample preparation. This study presents a new experimental setup named open immersion to measure a wide range of pharmaceutical tablets in their intact form. Besides, a series of data processing techniques to extract subtle features of the advancing liquid front are designed and utilised, effectively increasing the maximum thickness of tablets that can be analysed. We used the new method and successfully measured the liquid ingress profiles for a set of oval convex tablets prepared from a complex eroding immediate-release formulation.


Asunto(s)
Química Farmacéutica , Imágen por Terahertz , Química Farmacéutica/métodos , Radiación Terahertz , Comprimidos , Solubilidad , Tecnología Farmacéutica/métodos , Imágen por Terahertz/métodos
4.
Int J Pharm ; 592: 119980, 2021 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-33069892

RESUMEN

A new approach is proposed to support prediction of tablet tensile strength as a function of both solid fraction (and/or compression pressure) and extent of lubrication by using empirical data to parameterise the model. This is a pre-requisite for simulation of the compaction unit operation where a linkage from tablet press operating parameters and formulation material properties to output tensile strength is required. The approach extends the previously published Kushner and Moore model to allow calculation across a range of solid fractions. The applicability of the approach is supported by testing using formulations with different commonly used pharmaceutical excipients.


Asunto(s)
Excipientes , Composición de Medicamentos , Lubrificación , Polvos , Comprimidos , Resistencia a la Tracción
5.
Nat Commun ; 10(1): 2426, 2019 06 03.
Artículo en Inglés | MEDLINE | ID: mdl-31160578

RESUMEN

DNA replication initiation is a two-step process. During the G1-phase of the cell cycle, the ORC complex, CDC6, CDT1, and MCM2-7 assemble at replication origins, forming pre-replicative complexes (pre-RCs). In S-phase, kinase activities allow fork establishment through (CDC45/MCM2-7/GINS) CMG-complex formation. However, only a subset of all potential origins becomes activated, through a poorly understood selection mechanism. Here we analyse the pre-RC proteomic interactome in human cells and find C13ORF7/RNF219 (hereafter called OBI1, for ORC-ubiquitin-ligase-1) associated with the ORC complex. OBI1 silencing result in defective origin firing, as shown by reduced CMG formation, without affecting pre-RC establishment. OBI1 catalyses the multi-mono-ubiquitylation of a subset of chromatin-bound ORC3 and ORC5 during S-phase. Importantly, expression of non-ubiquitylable ORC3/5 mutants impairs origin firing, demonstrating their relevance as OBI1 substrates for origin firing. Our results identify a ubiquitin signalling pathway involved in origin activation and provide a candidate protein for selecting the origins to be fired.


Asunto(s)
Replicación del ADN/fisiología , Fase G1/fisiología , Complejo de Reconocimiento del Origen/metabolismo , Origen de Réplica/fisiología , Fase S/fisiología , Ubiquitina-Proteína Ligasas/metabolismo , Humanos , Complejo de Reconocimiento del Origen/genética , Proteómica , Ubiquitina-Proteína Ligasas/genética , Ubiquitinación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA